Pharmaceutical News 2.0

September 20, 2007
(excerpt)
By Laura MacInnis

GENEVA, Sept 20 (Reuters) - Improving access to medicine could save 10 million lives a year globally, a U.N. health envoy said on Thursday, recommending that drugmakers support research for neglected diseases and cut prices in poor countries.

Paul Hunt, an independent U.N. expert on the right to health, estimated that 2 billion people worldwide cannot get the essential drugs they need.

In about 50 recommendations released by the Office of the U.N. High Commissioner for Human Rights, Hunt urged drugmakers to charge less for medicines in poorer markets and allow developing states flexibility in accessing cheaper generics.

“It is time to identify what pharmaceutical companies should do to help realise the human right to medicine. How can we expect pharmaceutical companies to respect human rights if we fail to explain what they’re expected to do?” he said.

“The price of medicine in a low-income country should be less than the price of the same or equivalent medicine in a middle-income country, which should be less than the price of the same or equivalent medicine in a high-income country.”

Just 15 percent of the global population consumes more than 90 percent of the world’s pharmaceuticals, he added.

On patents, one of the most contentious issues in public health, Hunt said it was important pharmaceutical companies respect World Trade Organisation (WTO) rules and ease off lobbying for stricter patent protection in poorer states.

“The company should not extend patent duration, or file patents for new indications for existing medicines, in low-income and middle-income countries,” his guidelines said.

Read more on the need for better access to medicine.

access to medicine access to medicine

SAN DIEGO

THIS SUMMER, as part of a $91 billion farm bill, House lawmakers passed a measure to legalize the importation of prescription drugs from abroad. With so many recent stories of substandard and lethal goods already invading our shores, this is terrible public policy.

Supporters of drug importation think that simply because drugs are purchased from such “safe” countries as Canada and Britain, they are actually made there and are subject to strict health regulations and oversight. But this is a dangerous misconception.

Take Canada. If drugs are not earmarked for Canadian citizens, they are not subject to the Canadian government’s safety regulations. Just label the goods “for export only,” and Canada becomes a post-office box for fake or low-quality drugs from China, India, and other countries notorious for their ineffective and lethal products — as we’ve seen with everything from toothpaste to toys. And Canadian citizens themselves have been the victims of fake drugs. In Hamilton, Ontario, a registered pharmacist was recently charged with selling a counterfeit version of the blood-pressure drug Norvasc at his drugstore. Or look to Europe, where parallel trade — a process that allows the importation and re-importation of goods across EU-member states’ borders — is the standard.

At any point, counterfeiters can place fakes into the chain and pass them off with no one knowing the difference. This year, European officials warned of problems with phony drugs after seizing a large supply of such goods that had arrived from China by way of the United Arab Emirates. And several drug recalls have taken place in the United Kingdom after bogus drugs were detected in its supply chain.

Further, the Internet is a particularly worrying source of counterfeit imported drugs. In fact, World Health Organization officials estimate that 50 percent or more of drugs purchased online are fake. And tragic cases abound. A woman in Vancouver, for example, recently died from counterfeit meds purchased over the Internet. Internet drug pushers can and do put Canadian or British flags on their Web sites, claiming that their wares are Canadian, European, or even American in origin, regardless of the true source. It’s impossible to tell the difference — until it’s too late.

Unfortunately, the sheer number of criminal activities surrounding counterfeit-drug sales already overwhelms the Food and Drug Administration. With fewer than 17 full-time employees covering all international mail facilities in the United States, it is simply impossible for the FDA to inspect the 40,000 packages with drugs coming into Kennedy Airport, in New York, each day, let alone the millions coming into America each year at present.

Read the rest of this article on the potential for fake pills in the United States.

fake pills fake pills